RxDoctor Payments Data

Maliaka Jones, NP

Adult Health · Raleigh, NCNPI 1396954103

Payments from drug & device makers

$974in general payments, 2019–2025

Across 58 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$241
  • AstraZeneca$84
  • Grifols USA, LLC$83
  • Boehringer Ingelheim$82
  • Baxter Healthcare$74
  • United Therapeutics Corporation$68
  • plus $342 from 12 others

What the payments were for

  • Food & beverage$91794%
  • Education$576%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$974 in reported general payments places this provider in the 65th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$39,670
Medicare patients
236
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter687$558,808
Breo ElliptaFluticasone/Vilanterol229$111,399
Breztri AerosphereBudesonide/Glycopyr/Formoterol119$97,192
Spiriva RespimatTiotropium Bromide112$84,589
Stiolto RespimatTiotropium Br/Olodaterol Hcl78$50,862
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr65$40,736
SymbicortBudesonide/Formoterol Fumarate117$34,877
Spiriva HandihalerTiotropium Bromide36$25,880
Advair HfaFluticasone Propion/Salmeterol55$20,981
Albuterol Sulfate HfaAlbuterol Sulfate628$17,001
Fluticasone-SalmeterolFluticasone Propion/Salmeterol85$11,881
Incruse ElliptaUmeclidinium Bromide32$11,852
Arnuity ElliptaFluticasone Furoate42$10,393
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate41$8,980
Ventolin HfaAlbuterol Sulfate138$8,622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta$241$733,1881,055 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$82$135,451190 claims
AstraZenecaBreztri Aerosphere, Symbicort$84$132,068236 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 614 adult health providers in North Carolina.

Other adult health in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →